Schroeder Thilo's Form 4 filing
PMV Pharmaceuticals, Inc. (PMVP) · filed Aug 25, 2021
- Accession no.
- 0001209191-21-053389
- Filed
- Aug 25, 2021
- Trade date
- Aug 23-25, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 | Common Stock | SSaleDisposed | −23,138 | $30.66 | −$709,411.08 | 1,614,669 | Indirect | |
| Aug 23, 2021 | Common Stock | SSaleDisposed | −700 | $31.06 | −$21,742 | 1,613,969 | Indirect | |
| Aug 24, 2021 | Common Stock | SSaleDisposed | −14,490 | $31.08 | −$450,349.2 | 1,599,479 | Indirect | |
| Aug 25, 2021 | Common Stock | SSaleDisposed | −13,526 | $31.01 | −$419,441.26 | 1,585,953 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.